# Pfizer Inc. (PFE) — Q2-2012 Earnings Results

**Report date:** 2012-07-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q2-2012

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 1.39%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +12.52% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's performance. They are focused on product development and operational improvements.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They expressed confidence in ongoing research and development efforts.

> There was an emphasis on maintaining operational efficiency.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Pfizer's earnings report shows a positive surprise in EPS, which contributed to a 1.39% increase in stock price. The company did not provide revenue figures or future guidance, but management's comments suggest they are confident in their current strategies. Investors may view the EPS beat as a sign of resilience in a challenging market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q2-2012_